Ranbaxy aiming to sell its generics in Japan
Generics | News | By BioSpectrum Bureau | 0 Comment | 18 Nov, 2013
Singapore: Leading Indian generic drug maker, Ranbaxy Laboratories, along with its owners, Japan's second largest pharma...Read more
Ranbaxy claims FDA form '483' not a show stopper
Generics | News | By BioSpectrum Bureau | 0 Comment | 28 Jun, 2013
Singapore: Soon after reports of Ranbaxy's Mohali manufacturing plant being issued a Form 483 by the US US FDA broke out...Read more
Astellas joins hands with Tecnofarma International
Generics | News | By BioSpectrum Bureau | 0 Comment | 07 Jun, 2013
Singapore: The US subsidiary of Japanese drug major Astellas Pharma has entered into a distribution agreement with Tecno...Read more
Generic sodium tablets from Dr. Reddy's, Mylan hit US market
Generics | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2012
Mumbai: Dr. Reddy's Laboratories, India's leading pharmaceutical company, recently launched Montelukast Sodium Tablets a...Read more
Generics take center stage in South East Asia
Generics | Analysis | By BioSpectrum Bureau | 2 Comment | 21 Aug, 2013
Singapore: The South East Asian pharmaceuticals industry is forecast to witness a boost to $3.9 billion by 2016. The in...Read more
China: GSK used sexual bribery to boost sales
Generics | News | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2013
Singapore: The police in China have made it official that four senior Chinese executives of GlaxoSmithKline have been de...Read more
Mayne Pharma acquires generic drugmaker Libertas
Generics | News | By BioSpectrum Bureau | 0 Comment | 05 Jul, 2013
Singapore: Mayne Pharma from Australia has made a second US acquisition by buying privately-held US-based generic drugma...Read more
Bribery inquiries rising in China: SPP
Generics | News | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2013
Singapore: Chinese prosecutors have received more than 600,000 inquiries about bribery records involving companies or in...Read more
China bans GSK finance head from leaving country
Generics | News | By BioSpectrum Bureau | 0 Comment | 18 Jul, 2013
Singapore: Even as police in China are investigating claims of bribery against the British drug major for bribing doctor...Read more
UCB sues 15 firms for patent infringement
Generics | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2013
Singapore: In a move that is threatening to become a high profile patent infringement suit, global biopharma company UCB...Read more
Deregulation will boost Japanese pharma sector
Generics | News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Singapore: Japan's pharmaceutical industry is the second largest in the world, worth $89 billion in 2011 or 10 percent o...Read more
50% of all drug firms have counter-generics team
Generics | News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2013
Singapore: A report by Cutting Edge Information titled, 'Post-patent generic and biosimilar defense: Harnessing competit...Read more
Diabetes drug Actos banned in India
Generics | Regulatory | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2013
Singapore: The Indian Health Ministry has banned the blockbuster diabetes drug Actos along with suspending sales of pain...Read more
Reports: GSK staff detained in 'fraud data' case in China
Generics | News | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2013
Singapore: The Chinese police have reportedly detained employees of British pharmaceuticals major GlaxoSmithKline (GSK) ...Read more
Dr Yusuf K Hamied: India's generics king
Generics | Influencers | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2012
Dr Yusuf K Hamied, CMD of India's largest pharma company, Cipla, has earned many unflattering epithets for building a co...Read more
India to realign regulatory with pharma industry
Generics | Opinion | By Nandita Singh | 2 Comment | 06 Jun, 2012
India's top drug regulatory body, the Central Drug Standard Control Organization (CDSO) is literally facing the heat, th...Read more
Sun Pharma generic testosterone injection gets FDA nod
Generics | Regulatory | By BioSpectrum Bureau | 4 Comment | 06 Jun, 2013
Mumbai: Sun Pharmaceutical Industries received final approval from the US FDA for its abbreviated new drug application (...Read more
GlobalData: New Zealand focuses on generics
Generics | News | By BioSpectrum Bureau | 0 Comment | 27 Feb, 2013
Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emp...Read more